Virus-based nanocarriers for drug delivery

Advanced Drug Delivery Reviews

Volumn 64, Issue 9, 2012, Pages 811-825

  Ma, Yujie ^a,b   Nolte, Roeland J M ^b   Cornelissen, Jeroen J L M ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Bioconjugation; Drug delivery; Supramolecular chemistry; Targeting; Virus; Virus like particle (VLP)

Indexed keywords

BIO-CONJUGATION; BIODISTRIBUTIONS; BUILDING BLOCKES; DRUG PACKAGING; EFFICIENCY REQUIREMENTS; GENETIC MODIFICATIONS; INNER CAVITIES; NANOCARRIERS; OUTER SURFACE; PROTEIN CAGES; TARGETING; VIRUS-LIKE PARTICLES;

BIOCOMPATIBILITY; CHEMICAL MODIFICATION; DRUG DELIVERY; SUPRAMOLECULAR CHEMISTRY;

VIRUSES;

CAPSID PROTEIN; FULLERENE DERIVATIVE; NANOCARRIER; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; PORPHYRIN; QUANTUM DOT; VIRUS DNA; VIRUS RNA; VIRUS VECTOR;

BACTERIOPHAGE M13; BIOCOMPATIBILITY; COWPEA CHLOROTIC MOTTLE VIRUS; COWPEA MOSAIC VIRUS; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PACKAGING; DRUG TARGETING; DRUG TRANSPORT; FLOCK HOUSE VIRUS; GENE MUTATION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR RECOGNITION; MS2 VIRUS; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; NODAVIRUS; NONHUMAN; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PLANT VIRUS; PRIORITY JOURNAL; RED CLOVER NECROTIC MOSAIC VIRUS; REVIEW; SUPRAMOLECULAR CHEMISTRY; TOBACCO MOSAIC VIRUS; TURNIP YELLOW MOSAIC VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS PARTICLE;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG PACKAGING; HUMANS; NANOPARTICLES; VIRUSES;

EID: 84862777617     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.01.005     Document Type: Review

References (115)

1. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
2. Boas U., Heegaard P.M.H. Dendrimers for drug research. Chem. Soc. Rev. 2004, 33:43-63.
3. Lian T., Ho R.J.Y. Trends and developments in liposome drug delivery systems. J. Pharm. Sci-US 2001, 90:667-680.
4. Discher D.E., Ortiz V., Srinivas G., Klein M.L., Kim Y., David C.A., Cai S.S., Photos P., Ahmed F. Emerging applications of polymersomes in delivery: from molecular dynamics to shrinkage of tumors. Prog. Polym. Sci. 2007, 32:838-857.
5. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
6. Garcea R.L., Gissmann L. Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr. Opin. Biotechnol. 2004, 15:513-517.
7. Meldrum F.C., Wade V.J., Nimmo D.L., Heywood B.R., Mann S. Synthesis of inorganic nanophase materials in supramolecular protein cages. Nature 1991, 349:684-687.
8. Uchida M., Terashima M., Cunningham C.H., Suzuki Y., Willits D.A., Willis A.F., Yang P.C., Tsao P.S., McConnell M.V., Young M.J., Douglas T. A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn. Reson. Med. 2008, 60:1073-1081.
9. Kim K.K., Kim R., Kim S.H. Crystal structure of a small heat-shock protein. Nature 1998, 394:595-599.
10. Uchida M., Klem M.T., Allen M., Suci P., Flenniken M., Gillitzer E., Varpness Z., Liepold L.O., Young M., Douglas T. Biological containers:protein cages as multifunctional nanoplatforms. Adv. Mater. 2007, 19:1025-1042.
11. Flenniken M.L., Liepold L.O., Crowley B.E., Willits D.A., Young M.J., Douglas T. Selective attachment and release of a chemical therapeutic agent from the interior of a protein cage architecture. Chem. Commun. 2005, 4:447-449.
12. Liepold L.O., Abedin M.J., Buckhouse E.D., Frank J.A., Young M.J., Douglas T. Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett. 2009, 9:4520-4526.
13. Uchida M., Kosuge H., Terashima M., Willits D.A., Liepold L.O., Young M.J., McConnell M.V., Douglas T. Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. ACS Nano 2011, 4:2493-2502.
14. Schott K., Ladenstein R., Konig A., Bacher A. The lumazine synthase-riboflavin synthase complex of bacillus-crystallization of reconstituted icosahedral beta-subunit capsids. J. Biol. Chem. 1990, 265:12686-12689.
15. Kickhoefer V.A., Garcia Y., Mikyas Y., Johansson E., Zhou J.C., Raval-Fernandes S., Minoofar P., Zink J.I., Dunn B., Stewart P.L., Rome L.H. Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4348-4352.
16. Kutter E., Sulakyelidze A. Bacteriophage: Biology and Applications 2005, CRC press, Boca Raton.
17. Manchester M., Singh P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv. Drug Deliv. Rev. 2006, 58:1505-1522.
18. Strable E., Finn M.G. Chemical modifications of viruses and virus-like particles, viruses and nanotechnology. Curr. Top. Microbiol. 2009, 327:1-21.
19. Zhu Y.X., Carragher B., Kriegman D.J., Milligan R.A., Potter C.S. Automated identification of filaments in cryoelectron microscopy images. J. Struct. Biol. 2001, 135:302-312.
20. Hemminga M.A., Vos W.L., Nazarov P.V., Koehorst R.B.M., Wolfs C.J.A.M., Spruijt R.B., Stopar D. Eur. Biophys. J. 2010, 39:541-550.
21. Speir J.A., Munshi S., Wang G.J., Baker T.S., Johnson J.E. Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryoelectron microscopy. Structure 1995, 3:63-78.
22. Brumfield S., Willits D., Tang L., Johnson J.E., Douglas T., Young M. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle virus results in the assembly of protein cages with altered architectures and function. J. Gen. Virol. 2004, 85:1049-1053.
23. Tang J.H., Johnson J.M., Dryden K.A., Young M.J., Zlotnick A., Johnson J.E. The role of subunit hinges and molecular "switches" in the control of viral capsid polymorphism. J. Struct. Biol. 2006, 154:59-67.
24. Porta C., Spall V.E., Findlay K.C., Gergerich R.C., Farrance C.E., Lomonossoff G. Cowpea mosaic virus-based chimeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 2003, 310:50-63.
25. Singh P., Gonzalez M.J., Manchester M. Viruses and their uses in nanotechnology. Drug Dev. Res. 2006, 67:23-41.
26. Sherman M.B., Guenther R.H., Tama F., Sit T.L., Brooks C.L., Mikhailov A.M., Orlova E.V., Baker T.S., Lommel S.A. Removal of divalent cations induces structural transitions in Red clover necrotic mosaic virus revealing a potential mechanism for RNA release. J. Virol. 2006, 80:10395-10406.
27. Peabody D.S. A viral platform for chemical modification and multivalent display. J. Nanobiotechnol. 2003, 1:5.
28. Valegard K., Liljas L., Fridborg K., Unge T. The 2-dimentional structure of the bacterial-virus MS2. Nature 1990, 345:36-41.
29. Cargile B.J., McLuckey S.A., Stephenson J.L. Identification of bacteriophage MS2 coat protein from E. coli lysates via trap collisional activation of intact protein ions. Anal. Chem. 2001, 73:1277-1285.
30. Hooker J.M., Kovacs E.W., Francis M.B. Interior surface modification of bateriophage MS2. J. Am. Chem. Soc. 2004, 12:3718-3719.
31. Johnson H.R., Hooker J.M., Francis M.B., Clark D.S. Solubilization and stabilization of bacteriophage MS2 in organic solvents. Biotechnol. Bioeng. 2007, 97:224-234.
32. Brown S.D., Fiedler J.D., Finn M.G. Assembly of hybrid bacteriophage Q beta virus-like particles. Biochemistry-US 2009, 48:11155-11157.
33. Ashcroft A.E., Lago H., Macedo J.M.B., Horn W.T., Stonehouse N.J., Stockley P.G. Engineering thermal stability in RNA phage capsids via disulphide bonds. J. Nanosci. Nanotechnol. 2005, 5:2034-2041.
34. Valegard K., Fridborg K., Liljas L. Crystallization and preliminary X-ray diffraction studies of the bacteriophage Q-beta. Acta Crystallogr.-D 1994, 50:105-109.
35. Kozlovska T.M., Cielens I., Vasiljeva I., Strelnikova A., Kazaks A., Dislers A., Dreilina D., Ose V., Gusars I., Pumpens P. Intervirology 1996, 39:9-15.
36. Vasiljeva I., Kozlovska T., Cielens I., Strelnikova A., Kazaks A., Ose O., Pumpens P. Mosaic Q beta coats as a new presentation model. FEBS Lett. 1998, 431:7-11.
37. Prasuhn E.E., Singh P., Strable E., Brown S., Manchester M., Finn M.G. Plasma clearance of bacteriophage Q beta particles as a function of surface charge. J. Am. Chem. Soc. 2008, 130:1328-1334.
38. Nam K.T., Kim D.-W., Yoo P.J., Chiang C.-Y., Meethong N., Hammond P.T., Chiang Y.-M., Belcher A.M. Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes. Science 2006, 312:885-888.
39. Smith G.P., Petrenko V.A. Phage display. Chem. Rev. 1997, 97:391-410.
40. Chiang C.-Y., Mello C.M., Gu J., Silva E.C.C.M., van Vliet K.J., Belcher A.M. Weaving genetically engineered functionality into mechanically robust virus fibers. Adv. Mater. 2007, 19:826-832.
41. Lee Y.J., Yi H., Kim W.-J., Wang K., Yun D.S., Strano M.S., Ceder G., Belcher A.M. Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 2009, 324:1051-1055.
42. Schlick T.L., Ding Z., Kovacs E.W., Francis M.B. Dual-surface modification of the tobacco mosaic virus. J. Am. Chem. Soc. 2005, 127:3718-3723.
43. Lee L.A., Liu Z., Wang Q. Viruses and virus-like protein assemblies-chemically programmable nanoscale building blocks. Nano Res. 2009, 2:349-364.
44. Barnhill H.N., Reuther R., Ferguson P.L., Dreher T., Wang Q. Turnip yellow mosaic virus as a themoaddressable bionanoparticle. Bioconjugate Chem. 2007, 18:852-859.
45. Leimkuhler M., Goldbeck A., Lechner M.D., Adrian M., Michels B., Witz J. The formation of empty shells upon pressure induced decapsidation of turnip yellow mosaic virus. Arch. Virol. 2001, 146:653-667.
46. Kaper J.M. Alkaline degradation of Turnip yellow mosaic virus. 1. The controlled formation of empty protein shells. Biochemistry 1964, 3:486-493.
47. Katouzian-Safadi M., Favre A., Haenni A.-L. Effect of freezing and thawing on the structure of turnip yellow mosaic virus. Eur. J. Biochem. 1980, 112:479-486.
48. Singh P., Destito G., Schneemann A., Manchester M. Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. J. Nanobiotechnol. 2006, 4:2.
49. Robinson I.K., Harrison S.C. Structure of the expanded state of tomato bushy stunt virus. Nature 1982, 297:563-568.
50. Sorger P.K., Stockley P.G., Harrison S.C. Structure and assembly of turnip crinkle virus II. Mechanism of reassembly in vitro. J. Mol. Biol. 1986, 191:639-658.
51. Destito G., Schneemann A., Manchester M. Biomedical nanotechnology using virus-based nanoparticles, viruses and nanotechnology. Curr. Top. Microbiol. 2009, 327:95-122.
52. Douglas T., Young M. Viruses: making friends with old foes. Science 2006, 312:873-875.
53. Douglas T., Young M. Host-guest encapsulation of materials by assembled virus protein cages. Nature 1998, 393:152-155.
54. Comellas-Aragonès M., Engelkamp H., Claessen V.I., Sommerdijk N.A.J.M., Rowan A.E., Christianen P.C.M., Maan J.C., Verduin B.J.M., Cornelissen J.J.L.M., Nolte R.J.M. Nat. Nanotechnol. 2007, 2:635-639.
55. Sikkema F.D., Comellas-Aragonès M., Fokkink R.G., Verduin B.J.M., Cornelissen J.J.L.M., Nolte R.J.M. Monodisperse polymer-virus hybrid nanoparticles. Org. Biomol. Chem. 2007, 5:54-57.
56. Minten I.J., Hendriks L.J.A., Nolte R.J.M., Cornelissen J.J.L.M. Controlled encapsulation of multiple proteins in virus capsids. J. Am. Chem. Soc. 2009, 131:17771-17773.
57. Kwak M., Minten I.J., Anaya D.-M., Musser A.J., Brasch M., Nolte R.J.M., Müllen K., Cornelissen J.J.L.M., Herrmann A. Virus-like particles template by DNA micelles: a general method for loading virus nanocarriers. J. Am. Chem. Soc. 2010, 132:7834-7835.
58. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3:380-387.
59. Ali H., van Lier J.E. Metal complexes as photo- and radiosensitizers. Chem. Rev. 1999, 99:2379-2450.
60. Brasch M., de la Escosura A., Ma Y., Uetrecht C., Heck A.J.R., Torres T., Cornelissen J.J.L.M. Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. J. Am. Chem. Soc. 2011, 133:6878-6881.
61. Douglas T., Strable E., Willits D., Aitouchen A., Libera M., Young M. Protein engineering of a viral cage for constrained nanomaterial synthesis. Adv. Mater. 2002, 14:41-418.
62. Dixit S.K., Goicochea N.L., Daniel M.-C., Murali A., Bronstein L., De M., Stein B., Rotello V.M., Kao C.C., Dragnea B. Quantum dot encapsulation in viral capsids. Nano Lett. 2006, 6:1993-1999.
63. Li F., Zhang Z.-P., Peng J., Cui Z.-Q., Pang D.-W., Li K., Wei H.-P., Zhou Y.-F., Wen J.-K., Zhang X.-E. Imaging viral behavior in mammalian cells with self-assembled capsid-quantum-dot hybrid particles. Small 2009, 5:718-726.
64. Goicochea N.L., De M., Rotello V.M., Mukhopadhyay S., Dragnea B. Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. Nano Lett. 2007, 7:2281-2290.
65. Loo L., Guenther R.H., Lommel S.A., Franzen S. Encapsidation of nanoparticles by red clover necrotic mosaic virus. J. Am. Chem. Soc. 2007, 129:11111-11117.
66. Ren Y., Wong S.-M., Lim L.-Y. In vitro-reassembled plant virus-like particles for loading of polyacids. J. Gen. Virol. 2006, 87:2749-2754.
67. Ohtake N., Niikura K., Suzuki T., Nagakawa K., Mikuni S., Matsuo Y., Kinjo M., Sawa H., Ijiro K. Low pH-triggered model drug molecule release from virus-like particles. ChemBioChem 2010, 11:959-962.
68. Goldmann C., Stotle N., Nisslein T., Hunsmann G., Lüke W., Petry H. Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. J. Vitrol. Methods 2000, 90:85-90.
69. Gillitzer E., Willits D., Young M., Douglas T. Chemical modification of a viral cage for multivalent presentation. Chem. Commun. 2002, 2390-2391.
70. Suci P.A., Varpness Z., Gillitzer E., Douglas T., Young M. Targeting and photodynamic killing of a microbial pathogen using protein cage architecture functionalized with a photosensitizer. Langmuir 2007, 23:12280-12286.
71. Qu X., Komatsu T., Sato T., Glatter O., Horinouchi H., Kobayashi K., Tsuchida E. structure, photophysical property, and cytotoxicity of human serum albumin complexed with tris(cicarboxymethylene)[60]fullerene. Bioconjugate Chem. 2008, 19:1556-1560.
72. 24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. Chem. Res. Toxicol. 2008, 21:1056-1063.
73. Steinmetz N.F., Hong V., Spoerke E.D., Lu P., Breitenkamp K., Finn M.G., Manchester M. Buckyballs meet viral nanoparticles: candidates for biomedicine. J. Am. Chem. Soc. 2009, 131:17093-17095.
74. Li K., Chen Y., Li S., Hguyen H.G., Niu Z., You S., Mello C.M., Lu X., Wang Q. Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjugate Chem. 2010, 21:1369-1377.
75. Kovacs E.W., Hooker J.M., Romanini D.W., Holder P.G., Berry K.E., Francis M.B. Dual-surface modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjugate Chem. 2007, 18:1140-1147.
76. Stephanopoulos N., Tong G.J., Hsiao S.C., Francis M.B. Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. ACS Nano 2010, 4:6014-6020.
77. Zhao Q., Chen W., Chen Y., Zhang L., Zhang J., Zhang Z. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjugate Chem. 2011, 22:346-352.
78. Suci P., Klem M.T., Young M., Douglas T. Signal amplification using nanoplatform cluster formation. Soft Matter 2008, 4:2519-2523.
79. Ngweniform P., Abbineni G., Cao B., Mao C. Self-assembly of drug-loaded liposomes on genetically engineered target-recognized M13 phage: a novel nanocarrier for targeted delivery. Small 2009, 5:1963-1969.
80. Langer R. Drug delivery and targeting. Science 1998, 392:5-10.
81. Schmidt U., Rudolph R., Böhm G. Binding of external ligands onto an engineered virus capsid. Protein Eng. 2001, 14:769-774.
82. Rijnboutt S., Jansen G., Posthuma G., Hynes J.B., Schornagel J.H., Strous G.J. Endocytosis of GPI-linked membrane folate receptor-alpha. J. Cell Biol. 1996, 132:35-47.
83. Lu Y., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 2002, 54:675-693.
84. Ren Y., Wong S.M., Lim L.-Y. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for Doxorubicin. Bioconjugate Chem. 2007, 18:836-843.
85. Destito G., Yeh R., Rae C.S., Finn M.G., Manchester M. Folic acid-mediated targeting of Cowpea mosaic virus particles to tumor cells. Chem. Biol. 2007, 14:1152-1162.
86. Gupta S.S., Raja K.S., Kaltgrad E., Strable E., Finn M.G. Virus-glycopolymer conjugates by copper (I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. Chem. Commun. 2005, 4315-4317.
87. Daniels T.R., Delgado T., Helguera G., Penichet M.L. The transferring receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin. Immunol. 2006, 121:159-176.
88. Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., Penichet M.L. The transferring receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 2006, 121:144-158.
89. Gupta S.S., Kuzelka J., Singh P., Lewis W.G., Manchester M., Finn M.G. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjugate Chem. 2005, 16:1572-1579.
90. Banerjee D., Liu A.P., Voss N.R., Schmid S.L., Finn M.G. Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles. ChemBioChem 2010, 11:1273-1279.
91. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Brit. J. Pharmacol. 2009, 2:195-206.
92. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
93. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:664-668.
94. Wei B., Wei Y., Zhang K., Wang J., Xu R., Zhan S., Lin G., Wang W., Liu M., Wang L., Zhang R., Li J. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell penetrating peptide. Biomed. Pharmacother. 2009, 63:313-318.
95. Carrico Z.M., Romanini D.W., Mehl R.A., Francis M.B. Oxidative coupling of peptides to a virus capsid containing unnatural amino acids. Chem. Commun. 2008, 1205-1207.
96. Behrens C.R., Hooker J.M., Obermeyer A.C., Romanini D.W., Katz E.M., Francis M.B. Rapid chemoselective bioconjugation through oxidative coupling of anilines and aminophenols. J. Am. Chem. Soc. 2011, 133:16398-16401.
97. Seim K.L., Obermeyer A.C., Francis M.B. Oxidative modification of native protein residues using cerium (IV) ammonium nitrate. J. Am. Chem. Soc. 2011, 133:16970-16976.
98. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
99. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment-RNA ligands to bacteriophage-T4 DNA-polymerase. Science 1990, 249:505-510.
100. Eulberg D., Klussmann S. Spiegelmers: biostable aptamers. ChemBioChem 2003, 4:979-983.
101. Tong G.J., Hsiao S.C., Carrico Z.M., Francis M.B. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J. Am. Chem. Soc. 2009, 131:11174-11178.
102. Wickham T.J., Tzeng E., Shears L.L., Roelvink P.W., Li Y., Lee G.M., Brough D.E., Lizonova A., Kovesdi I. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 1997, 71:8221-8229.
103. Vigne E., Mahfouz I., Dedieu J.-F., Brie A., Perricaudet M., Yeh P. RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with t fiber knob-independent pathway for infection. J. Virol. 1999, 73:5156-5161.
104. Schmidt U., Rudolph R., Böhm G. Binding of external ligands onto an engineered virus capsid. Protein Eng. 2001, 14:769-774.
105. Koepf E.K., Petrassi H.M., Ratnaswamy G., Huff M.E., Sudol M., Kelly J.W. Characterization of the structure and function of W→F WW domain variants: identification of a natively unfolded protein that folds upon ligand binding. Biochemistry 1999, 38:14338-14351.
106. Chen L., Zurita A.J., Ardelt P.U., Giordano R.J., Arap W., Pasqualini R. Design and validation of a bifunctional ligand display system for receptor targeting. Chem. Biol. 2004, 11:1081-1091.
107. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 2006, 90:296-303.
108. Moghimi S., Hunter A.C., Murray J.C. Long-circulating target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53:283-318.
109. Kaiser C.R., Flenniken M.L., Gillitzer E., Harmsen A.L., Harmsen A.G., Jutila M.A., Douglas T., Young M. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int. J. Nanomed. 2007, 2:715-733.
110. Singh P., Prasuhn D., Yeh R.M., Destito G., Rae C.S., Osborn K., Finn M.G., Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J. Control. Release 2007, 120:41-50.
111. Raja K.S., Wang Q., Gonzalez M.J., Manchester M., Johnson J.E., Finn M.G. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules 2003, 4:472-476.
112. Lewis J.D., Destito G., Zijlstra A., Gonzalez M.J., Quigley J.P., Manchester M., Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat. Med. 2006, 12:354-360.
113. Leong H.S., Steinmetz N.F., Ablack A., Destito G., Zijstra A., Stuhlmann H., Manchester M., Lewis J.D. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat. Protoc. 2010, 5:1406-1417.
114. Koudelka K.J., Destito G., Plummer E.M., Trauger S.A., Siuzdak G., Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLOS Pathog. 2009, 5:e1000417.
115. Gonzalez M.J., Plummer E.M., Rae C.S., Manchester M. Interaction of cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One 2009, 4:e7981.